+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Disulfiram Market - Global Forecast 2025-2030- Product Image
Disulfiram Market - Global Forecast 2025-2030- Product Image
Sale

Disulfiram Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082578
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Disulfiram Market is experiencing significant momentum, driven by increased clinical applications, innovation in therapy delivery, and evolving healthcare frameworks. This report delivers actionable insights into market forces and trends shaping decision-making for senior leaders across the pharmaceutical sector.

Market Snapshot: Disulfiram Market Performance and Growth Outlook

The Disulfiram Market grew from USD 392.75 million in 2024 to USD 412.73 million in 2025. It is projected to sustain a CAGR of 4.85%, reaching USD 521.90 million by 2030. Rising demand for effective alcohol dependence therapies, together with expanding off-label psychiatric uses, are fueling steady market expansion. Adoption is also influenced by treatment innovation, regulatory shifts, and patient-centric technologies, shaping a dynamic competitive landscape for manufacturers, payors, and care providers.

Scope & Segmentation

This analysis offers a comprehensive view of the market segmentation and regional coverage. Key coverage areas include:

  • Manufacturer Types: Branded, Generic
  • Indications: Alcohol Dependence (Initial Therapy, Maintenance Therapy), Off-Label (Psychiatric Disorders, Substance Use Disorders)
  • Distribution Channels: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • End Users: Inpatient, Outpatient
  • Dosage Strengths: 250 mg, 500 mg
  • Therapy Regimens: Combination Therapy (with Acamprosate, with Naltrexone), Monotherapy
  • Regions Covered: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Featured Companies: Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Viatris Inc., Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Ltd., Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Limited

Key Takeaways for Decision-Makers

  • Disulfiram’s established use in alcohol dependence underpins growth, but new clinical protocols are extending its relevance into psychiatric and substance use disorders.
  • Regulatory enhancements, such as streamlined pathways for repurposed drugs, are enabling expanded label indications and faster market entry for alternative formulations.
  • Digital health ecosystems and telepsychiatry are enhancing patient monitoring, supporting adherence, and informing real-time treatment adjustments—particularly beneficial for outpatient populations.
  • Sustained-release and combination therapies are emerging as key strategies to address challenges in long-term compliance and improve therapeutic outcomes.
  • Competitive dynamics reflect a balance between established branding and cost-driven generic entry, intensifying the need for innovation and operational flexibility.
  • Regional performance is being shaped by disparities in reimbursement policy, healthcare infrastructure, and local manufacturing capabilities, affecting both accessibility and pricing strategies.

Tariff Impact

Recent United States tariff adjustments have increased costs for imported pharmaceutical components, prompting manufacturers to reevaluate sourcing and supply chain strategies. These changes have spurred shifts toward domestic API synthesis and new inventory management practices, affecting both pricing and access across hospital, retail, and online pharmacy environments. Payors and healthcare programs are adjusting reimbursement plans to maintain accessibility despite cost inflation, while continuous monitoring of trade policies remains critical for supply chain resilience.

Methodology & Data Sources

Findings are based on a rigorous blend of primary interviews with opinion leaders and executives, comprehensive secondary research from peer-reviewed sources, and deep regulatory and market data review. Data triangulation and expert panels assured analytical consistency and validated trends, allowing for targeted, actionable guidance for stakeholders navigating the Disulfiram Market.

Why This Report Matters

  • Facilitates strategic planning by illuminating key clinical, technological, and regulatory drivers influencing market evolution.
  • Delivers actionable insights for supply chain, pricing, and market access—critical for leaders directing commercial or investment strategies.
  • Supports targeted product development and regional entry decisions with robust segmentation and performance analysis across leading territories and companies.

Conclusion

Disulfiram’s market position as a cornerstone therapy continues to strengthen amid clinical expansion and evolving therapies. Stakeholders equipped with forward-looking insights and adaptive strategies can maximize growth and long-term value in a complex regulatory and competitive environment.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising off-label investigation of disulfiram for cancer and neurological disorders including repurposing efforts
5.2. Increasing integration of nanoparticle drug delivery systems to enhance the bioavailability of disulfiram
5.3. Growing market competition from alternative anti-addiction therapies challenging disulfiram dominance
5.4. Impact of generic drug pricing pressures on disulfiram profitability and manufacturer strategies
5.5. Expansion of government-supported public health programs promoting disulfiram for alcohol use disorder
5.6. Advances in sustained release formulations to improve patient adherence to disulfiram therapy
5.7. Emergence of real world evidence studies evaluating disulfiram efficacy in diverse patient populations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Disulfiram Market, by Manufacturer Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Disulfiram Market, by Indication
9.1. Introduction
9.2. Alcohol Dependence
9.2.1. Initial Therapy
9.2.2. Maintenance Therapy
9.3. Off Label
9.3.1. Psychiatric Disorders
9.3.2. Substance Use Disorders
10. Disulfiram Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Disulfiram Market, by End User
11.1. Introduction
11.2. Inpatient
11.3. Outpatient
12. Disulfiram Market, by Dosage Strength
12.1. Introduction
12.2. 250 Mg
12.3. 500 Mg
13. Disulfiram Market, by Therapy Regimen
13.1. Introduction
13.2. Combination Therapy
13.2.1. With Acamprosate
13.2.2. With Naltrexone
13.3. Monotherapy
14. Americas Disulfiram Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Disulfiram Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Disulfiram Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Bausch Health Companies Inc.
17.3.2. Teva Pharmaceutical Industries Ltd.
17.3.3. Sandoz International GmbH
17.3.4. Viatris Inc.
17.3.5. Dr. Reddy's Laboratories Ltd.
17.3.6. Sun Pharmaceutical Industries Ltd.
17.3.7. Cipla Ltd.
17.3.8. Lupin Limited
17.3.9. Glenmark Pharmaceuticals Ltd.
17.3.10. Torrent Pharmaceuticals Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DISULFIRAM MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DISULFIRAM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DISULFIRAM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DISULFIRAM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DISULFIRAM MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DISULFIRAM MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DISULFIRAM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DISULFIRAM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DISULFIRAM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DISULFIRAM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DISULFIRAM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DISULFIRAM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DISULFIRAM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DISULFIRAM MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. DISULFIRAM MARKET: RESEARCHAI
FIGURE 28. DISULFIRAM MARKET: RESEARCHSTATISTICS
FIGURE 29. DISULFIRAM MARKET: RESEARCHCONTACTS
FIGURE 30. DISULFIRAM MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DISULFIRAM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DISULFIRAM MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DISULFIRAM MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DISULFIRAM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DISULFIRAM MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DISULFIRAM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DISULFIRAM MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DISULFIRAM MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DISULFIRAM MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DISULFIRAM MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DISULFIRAM MARKET SIZE, BY INITIAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DISULFIRAM MARKET SIZE, BY INITIAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DISULFIRAM MARKET SIZE, BY MAINTENANCE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DISULFIRAM MARKET SIZE, BY MAINTENANCE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DISULFIRAM MARKET SIZE, BY OFF LABEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DISULFIRAM MARKET SIZE, BY OFF LABEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DISULFIRAM MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DISULFIRAM MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DISULFIRAM MARKET SIZE, BY SUBSTANCE USE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DISULFIRAM MARKET SIZE, BY SUBSTANCE USE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DISULFIRAM MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DISULFIRAM MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DISULFIRAM MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DISULFIRAM MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DISULFIRAM MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DISULFIRAM MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DISULFIRAM MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DISULFIRAM MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DISULFIRAM MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DISULFIRAM MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DISULFIRAM MARKET SIZE, BY 250 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DISULFIRAM MARKET SIZE, BY 250 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DISULFIRAM MARKET SIZE, BY 500 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DISULFIRAM MARKET SIZE, BY 500 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DISULFIRAM MARKET SIZE, BY WITH ACAMPROSATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DISULFIRAM MARKET SIZE, BY WITH ACAMPROSATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DISULFIRAM MARKET SIZE, BY WITH NALTREXONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DISULFIRAM MARKET SIZE, BY WITH NALTREXONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DISULFIRAM MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DISULFIRAM MARKET SIZE, BY MONOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS DISULFIRAM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES DISULFIRAM MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES DISULFIRAM MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 105. CANADA DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 106. CANADA DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 107. CANADA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 108. CANADA DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 109. CANADA DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 110. CANADA DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 111. CANADA DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 112. CANADA DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 113. CANADA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. CANADA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. CANADA DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. CANADA DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. CANADA DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 118. CANADA DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 119. CANADA DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 120. CANADA DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 121. CANADA DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 122. CANADA DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 123. MEXICO DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 124. MEXICO DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 125. MEXICO DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 126. MEXICO DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 127. MEXICO DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 131. MEXICO DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. MEXICO DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. MEXICO DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. MEXICO DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. MEXICO DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 136. MEXICO DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 137. MEXICO DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 138. MEXICO DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 139. MEXICO DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 140. MEXICO DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 215. GERMANY DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 216. GERMANY DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 217. GERMANY DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 218. GERMANY DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 219. GERMANY DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 220. GERMANY DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 221. GERMANY DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 222. GERMANY DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 223. GERMANY DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. GERMANY DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. GERMANY DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. GERMANY DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. GERMANY DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 228. GERMANY DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 229. GERMANY DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 230. GERMANY DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 231. GERMANY DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 232. GERMANY DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 233. FRANCE DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 234. FRANCE DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 235. FRANCE DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 236. FRANCE DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 237. FRANCE DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 238. FRANCE DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 239. FRANCE DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 240. FRANCE DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 241. FRANCE DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. FRANCE DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. FRANCE DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. FRANCE DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. FRANCE DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 246. FRANCE DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 247. FRANCE DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 248. FRANCE DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 249. FRANCE DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 250. FRANCE DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 269. ITALY DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 270. ITALY DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 271. ITALY DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 272. ITALY DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 273. ITALY DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 274. ITALY DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 275. ITALY DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 276. ITALY DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 277. ITALY DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. ITALY DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. ITALY DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. ITALY DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. ITALY DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 282. ITALY DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 283. ITALY DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 284. ITALY DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 285. ITALY DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 286. ITALY DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 287. SPAIN DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 288. SPAIN DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 289. SPAIN DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 290. SPAIN DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 291. SPAIN DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 292. SPAIN DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 293. SPAIN DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 294. SPAIN DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 295. SPAIN DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. SPAIN DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. SPAIN DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. SPAIN DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. SPAIN DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 300. SPAIN DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 301. SPAIN DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 302. SPAIN DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 303. SPAIN DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 304. SPAIN DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 324. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 326. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 328. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 330. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 336. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 338. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 340. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 341. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 342. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 343. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 344. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 345. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 346. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 347. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 348. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 349. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 350. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 351. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 352. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 353. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 354. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 355. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 356. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 357. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 358. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 359. DENMARK DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 360. DENMARK DISULFIRAM MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 361. DENMARK DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 362. DENMARK DISULFIRAM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 363. DENMARK DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2024 (USD MILLION)
TABLE 364. DENMARK DISULFIRAM MARKET SIZE, BY ALCOHOL DEPENDENCE, 2025-2030 (USD MILLION)
TABLE 365. DENMARK DISULFIRAM MARKET SIZE, BY OFF LABEL, 2018-2024 (USD MILLION)
TABLE 366. DENMARK DISULFIRAM MARKET SIZE, BY OFF LABEL, 2025-2030 (USD MILLION)
TABLE 367. DENMARK DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
T

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Disulfiram market report include:
  • Bausch Health Companies Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Viatris Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Ltd.
  • Lupin Limited
  • Glenmark Pharmaceuticals Ltd.
  • Torrent Pharmaceuticals Limited

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 412.73 Million
Forecasted Market Value ( USD ) by 2030 $ 521.9 Million
Compound Annual Growth Rate4.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Disulfiram (CAS 97-77-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Disulfiram (CAS 97-77-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Addiction Disorders Drugs Market - Global Forecast 2025-2030 - Product Image

Addiction Disorders Drugs Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Alcohol Use Disorder Market - Global Forecast 2025-2030 - Product Image

Alcohol Use Disorder Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Addictions Therapeutics Market Report 2025 - Product Image

Addictions Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cocaine Use Disorder - Pipeline Insight, 2025 - Product Image

Cocaine Use Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • 50 Pages
  • Global
From

About the Disulfiram Market

The Disulfiram market is a segment of the Addiction Disorders Drugs market. Disulfiram is a medication used to treat alcohol use disorder (AUD). It works by blocking the breakdown of alcohol, causing unpleasant side effects when alcohol is consumed. It is used as an aid to help people abstain from drinking alcohol. Disulfiram is available in tablet form and is taken orally. It is also available in an injectable form. The Disulfiram market is highly competitive, with many companies offering generic versions of the drug. Companies in the market include Mylan, Teva Pharmaceuticals, Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Cipla. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.